Annual Report

Overview

The report covers the Group's 2025 ESG performance across its pharmaceutical and fitness businesses. It reports 100% photovoltaic green energy consumption in the pharmaceutical business, one work-related fatality and 3 lost work-injury days. The report also presents TCFD-referenced climate disclosures and states a qualitative ambition to achieve net-zero emissions by 2050.

Document

Report type: Annual Report with Sustainability Disclosures
Class: Embedded
Scope: Full report
Fiscal year: 2025
Period: 1 January 2025 – 31 December 2025
Publication date: 27 March 2026
Language: English, Chinese
Pages
File size

Reporting standards, commitments and assurance details are available with a free account.

Standards

GRI
SASB
TCFD
ISSB
ESRS
Integrated Reporting Framework
GHG Protocol
EU Taxonomy
CDP

Materiality

Assessment
Basis

Assurance

Statement included

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services